CNBC Africa


South Africa’s drugs regulator to start assessing Sinovac COVID-19 vaccine

PUBLISHED: Fri, 12 Mar 2021 07:01:18 GMT

JOHANNESBURG, March 12 (Reuters) – South Africa’s medicines regulator SAHPRA said on Friday that it had received documentation for the COVID-19 vaccine developed by China’s Sinovac.

It added in a statement that it would now start evaluating the data and assessing the efficacy of the vaccine. (Reporting by Alexander Winning; Editing by Christopher Cushing)

(c) Copyright Thomson Reuters 2021. Click For Restrictions –